JP2022521453A5 - - Google Patents
Info
- Publication number
- JP2022521453A5 JP2022521453A5 JP2021542338A JP2021542338A JP2022521453A5 JP 2022521453 A5 JP2022521453 A5 JP 2022521453A5 JP 2021542338 A JP2021542338 A JP 2021542338A JP 2021542338 A JP2021542338 A JP 2021542338A JP 2022521453 A5 JP2022521453 A5 JP 2022521453A5
- Authority
- JP
- Japan
- Prior art keywords
- atoms
- het
- pharmaceutically acceptable
- stereoisomer
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19152928 | 2019-01-22 | ||
| EP19152928.8 | 2019-01-22 | ||
| PCT/EP2020/051210 WO2020152067A1 (en) | 2019-01-22 | 2020-01-20 | Heterocyclic derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521453A JP2022521453A (ja) | 2022-04-08 |
| JP2022521453A5 true JP2022521453A5 (enExample) | 2023-01-30 |
Family
ID=65199328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542338A Pending JP2022521453A (ja) | 2019-01-22 | 2020-01-20 | 複素環式の誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220062258A1 (enExample) |
| EP (1) | EP3914590B1 (enExample) |
| JP (1) | JP2022521453A (enExample) |
| KR (1) | KR20210118884A (enExample) |
| CN (1) | CN113348168A (enExample) |
| AU (1) | AU2020211684A1 (enExample) |
| BR (1) | BR112021014220A2 (enExample) |
| CA (1) | CA3127268A1 (enExample) |
| ES (1) | ES2934986T3 (enExample) |
| IL (1) | IL285025A (enExample) |
| MX (1) | MX2021008712A (enExample) |
| SG (1) | SG11202107893XA (enExample) |
| WO (1) | WO2020152067A1 (enExample) |
| ZA (1) | ZA202106024B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021038419A1 (en) * | 2019-08-23 | 2021-03-04 | Insilico Medicine Ip Limited | Kinase inhibitors and methods of synthesis and treatment |
| US12293809B2 (en) | 2019-08-23 | 2025-05-06 | Insilico Medicine Ip Limited | Workflow for generating compounds with biological activity against a specific biological target |
| CA3213624A1 (en) * | 2021-03-28 | 2022-10-06 | Canwell Biotech Limited | Metap-2 inhibitors, pharmaceutical compositions and therapeutic methods thereof |
| US20250032625A1 (en) | 2021-11-02 | 2025-01-30 | Merck Patent Gmbh | Heterobifunctional molecules as tead inhibitors |
| WO2023144053A1 (en) | 2022-01-26 | 2023-08-03 | Merck Patent Gmbh | Heterocyclic derivatives |
| CN116854604B (zh) * | 2023-06-27 | 2026-03-24 | 中国科学院微生物研究所 | 一种ω-氨基脂肪酸甲酯、长链尼龙的制备方法 |
| CN119569617A (zh) * | 2025-02-07 | 2025-03-07 | 成都普康唯新生物科技有限公司 | 一种磷酸酯脂肪烷酸及其中间体的合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002020740A2 (en) | 2000-09-08 | 2002-03-14 | California Institute Of Technology | Proteolysis targeting chimeric pharmaceutical |
| JP2010531896A (ja) * | 2007-06-26 | 2010-09-30 | チルドレンズ メディカル センター コーポレーション | 治療的投与のためのＭｅｔＡＰ−２阻害剤ポリマーソーム |
| DE102009005193A1 (de) * | 2009-01-20 | 2010-07-22 | Merck Patent Gmbh | Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren |
| DE102010048374A1 (de) * | 2010-10-13 | 2012-04-19 | Merck Patent Gmbh | Pyrrolidinone als MetAP-2 Inhibitoren |
| DE102012006884A1 (de) * | 2012-04-04 | 2013-10-10 | Merck Patent Gmbh | Cyclische Amide als MetAP-2 Inhibitoren |
| WO2014180524A1 (en) * | 2013-05-06 | 2014-11-13 | Merck Patent Gmbh | Macrocycles as kinase inhibitors |
| US20180228907A1 (en) * | 2014-04-14 | 2018-08-16 | Arvinas, Inc. | Cereblon ligands and bifunctional compounds comprising the same |
| KR102485537B1 (ko) | 2014-08-04 | 2023-01-05 | 메르크 파텐트 게엠베하 | Metap-2 저해제로서의 피롤리디논 유도체 |
| KR20180132861A (ko) * | 2016-04-12 | 2018-12-12 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | Bet 단백질 분해제 |
| GB201614134D0 (en) * | 2016-08-18 | 2016-10-05 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| CN107540608B (zh) | 2017-07-17 | 2021-10-19 | 大连理工大学 | 4-取代萘酰亚胺类化合物及其应用 |
-
2020
- 2020-01-20 KR KR1020217026596A patent/KR20210118884A/ko not_active Withdrawn
- 2020-01-20 ES ES20700833T patent/ES2934986T3/es active Active
- 2020-01-20 WO PCT/EP2020/051210 patent/WO2020152067A1/en not_active Ceased
- 2020-01-20 US US17/424,240 patent/US20220062258A1/en not_active Abandoned
- 2020-01-20 EP EP20700833.5A patent/EP3914590B1/en active Active
- 2020-01-20 CA CA3127268A patent/CA3127268A1/en active Pending
- 2020-01-20 CN CN202080010269.1A patent/CN113348168A/zh active Pending
- 2020-01-20 SG SG11202107893XA patent/SG11202107893XA/en unknown
- 2020-01-20 BR BR112021014220A patent/BR112021014220A2/pt not_active Application Discontinuation
- 2020-01-20 MX MX2021008712A patent/MX2021008712A/es unknown
- 2020-01-20 AU AU2020211684A patent/AU2020211684A1/en not_active Abandoned
- 2020-01-20 JP JP2021542338A patent/JP2022521453A/ja active Pending
-
2021
- 2021-07-21 IL IL285025A patent/IL285025A/en unknown
- 2021-08-20 ZA ZA2021/06024A patent/ZA202106024B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022521453A5 (enExample) | ||
| JP7158383B2 (ja) | Ｃ－ｋｉｔ阻害剤としてのベンズイミダゾール化合物 | |
| KR102746242B1 (ko) | Ｒｓｋ 억제제로서 유용한 카르복사미드 유도체 | |
| JP2022185107A (ja) | Ｃ－ｋｉｔ阻害剤としてのアミノチアゾール化合物 | |
| HRP20161032T1 (hr) | Ciklički amidi kao inhibitori metap-2 | |
| ES2551095T3 (es) | Amidas heterocíclicas de 5 miembros y compuestos relacionados | |
| ES2741896T3 (es) | Compuestos de heterociclilo | |
| US20220204517A1 (en) | Inhaled powder formulations | |
| US20210230144A1 (en) | Irak degraders and uses thereof | |
| ES2807785T3 (es) | Compuestos de heteroarilamina bicíclicos como inhibidores de pi3k | |
| JP2009524670A5 (enExample) | ||
| US9725445B2 (en) | Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors | |
| JP2018522847A5 (enExample) | ||
| HRP20160249T1 (hr) | Pirolidinoni kao inhibitori metap2 | |
| AU2010307006A1 (en) | Hematopoietic growth factor mimetic small molecule compounds and their uses | |
| TWI895318B (zh) | 組合 | |
| JP2017518348A5 (enExample) | ||
| CN107849044B (zh) | 作为ddr1抑制剂的三氮杂-螺癸酮类化合物 | |
| JP6687635B2 (ja) | オートタキシン阻害剤 | |
| WO2020168927A1 (zh) | 含氮并环化合物、其制备方法及用途 | |
| AU2018351559A1 (en) | Heterocyclic compounds, compositions comprising heterocyclic compound, and methods of use thereof | |
| JP7376358B2 (ja) | オピオイド受容体調節因子としての多環式アミン | |
| BR112019013287A2 (pt) | compostos de pirazolopirimidina e métodos de uso dos mesmos | |
| CN115038450A (zh) | 组合 | |
| EP4341254A1 (en) | Inhibitors and degraders of pip4k protein |